Document Type

Article

Publication Date

4-23-2018

Publication Title

BMC Public Health

Abstract

The current vaccine against tuberculosis, BCG, is effective when given in most TB-endemic countries at birth but has diminished efficacy against pulmonary TB after 15–20 years. As a result, new booster vaccines for adolescents and adults are being developed to realize the World Health Organization target of global elimination of TB by 2035. Multiple TB candidates thus are in active clinical development.

DOI

10.1186/s12889-018-5460-3

Comments

Open Access publishing fee supported by the Dartmouth Open Access Publishing fund.

Share

COinS